Importantly, our results showed that all tested compounds significantly decreased P-gp expression in MDR colorectal carcinoma cells, implying a cell type differential effect on P-gp expression between non-small cell lung carcinoma and colorectal carcinoma cells. The gene discussed is PGP; the disease is colorectal carcinoma.